Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology

ThyroSeq v2 claims high positive (PPV) and negative (NPV) predictive values in a wide range of pretest risks of malignancy in indeterminate thyroid nodules (ITNs) (categories B-III and B-IV of the Bethesda system). We evaluated ThyroSeq v2 performance in a cohort of patients with ITNs seen at our Ac...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Endocr Relat Cancer
Main Authors: Valderrabano, Pablo, Khazai, Laila, Leon, Marino E, Thompson, Zachary J, Ma, Zhenjun, Chung, Christine H, Hallanger-Johnson, Julie E, Otto, Kristen J, Rogers, Kara D, Centeno, Barbara A, McIver, Bryan
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7771306/
https://ncbi.nlm.nih.gov/pubmed/28104680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-16-0512
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki